Jazz Pharmaceuticals holds the cleaner structural position, with valuation as the main driver and profitability adding further support. Alcon does not offset that deficit through any equally strong structural edge elsewhere. On the market side, Jazz Pharmaceuticals is in better shape — its trend is intact while Alcon's trend has broken down. That puts structure and market broadly in agreement — Jazz Pharmaceuticals's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels.
The clearest score difference appears in valuation. The overall score gap is 23 points in favour of Jazz Pharmaceuticals plc.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
The pair still fits the compare framework, though the long-term structural overlap is relatively light.
The strongest overlap appears in revenue stability and investment intensity.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
The two profiles are relatively close, but the price setup still leans toward Jazz Pharmaceuticals plc.
Valuation position uses peer-relative PE percentile (idx_pct_pe) and Forward P/E where available.
The multiple-based pricing edge comes from a forward P/E that is 9.9 turns lower.
Stability is the one area where Alcon Inc. still pushes back materially — it is the steadier name on this dimension, which keeps the result from reading as one-way.
Valuation is the clearest driver, and profitability also supports Jazz Pharmaceuticals plc's broader structural position.
Break down the ALC.SW vs JAZZ comparison across all dimensions with the full interactive tool.
Explore how ALC.SW and JAZZ each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.